These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34433729)

  • 21. Pharmacotherapy for nontuberculous mycobacterial pulmonary disease.
    Velagapudi M; Sanley MJ; Ased S; Destache C; Malesker MA
    Am J Health Syst Pharm; 2022 Mar; 79(6):437-445. PubMed ID: 34788375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.
    Kamata H; Asakura T; Suzuki S; Namkoong H; Yagi K; Funatsu Y; Okamori S; Uno S; Uwamino Y; Fujiwara H; Nishimura T; Ishii M; Betsuyaku T; Hasegawa N
    BMC Pulm Med; 2017 Dec; 17(1):198. PubMed ID: 29237500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence.
    Yotsumoto T; Inoue Y; Fukami T; Matsui H
    Gen Thorac Cardiovasc Surg; 2020 Sep; 68(9):993-1002. PubMed ID: 32146579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease.
    Hara R; Kitada S; Iwai A; Kuge T; Oshitani Y; Kagawa H; Tsujino K; Yoshimura K; Miki M; Miki K; Kida H
    Ann Am Thorac Soc; 2020 Dec; 17(12):1536-1541. PubMed ID: 32915655
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study.
    Tanaka H; Asakura T; Suzuki S; Okamori S; Kusumoto T; Ogawa T; Uno S; Morita A; Lee H; Namkoong H; Kamata H; Sato Y; Uwamino Y; Nishimura T; Ishii M; Fukunaga K; Hasegawa N
    BMC Pulm Med; 2022 May; 22(1):202. PubMed ID: 35596169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coinfection With Multiple Nontuberculous Mycobacteria as a Possible Exacerbating Factor in Pulmonary Nontuberculous Mycobacteriosis: Clone Library Analysis Using the 16S Ribosomal RNA Gene.
    Naito K; Noguchi S; Yatera K; Kawanami T; Yamasaki K; Fukuda K; Ikegami H; Akata K; Kido T; Sakamoto N; Saito M; Mukae H
    Chest; 2020 Dec; 158(6):2304-2313. PubMed ID: 32599068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia.
    Eliseev P; Hinderaker SG; Heldal E; Tarasova I; Grjibovski A; Mariandyshev A
    Infect Genet Evol; 2019 Sep; 73():358-361. PubMed ID: 31163274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease.
    Mourad A; Baker AW; Stout JE
    Clin Infect Dis; 2021 May; 72(10):e552-e557. PubMed ID: 32856690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age- and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016.
    Park Y; Kim CY; Park MS; Kim YS; Chang J; Kang YA
    Korean J Intern Med; 2020 Nov; 35(6):1424-1431. PubMed ID: 32550717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in quality of life and functional capacity after lung transplantation: A single-center experience.
    Ricotti S; Martinelli V; Caspani P; Monteleone S; Petrucci L; Dalla Toffola E; Klersy C
    Monaldi Arch Chest Dis; 2017 Dec; 87(3):831. PubMed ID: 29424193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease.
    Matsumura Y; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Mori K; Ono K; Kawahara K; Omatsu S; Furuuchi K; Fujiwara K; Morimoto K; Kimura H; Senjyu H
    Int J Tuberc Lung Dis; 2022 Apr; 26(4):310-316. PubMed ID: 35351235
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease.
    Henkle E; Winthrop KL; Ranches GP; Plinke W; Litvin HK; Quittner AL
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31619467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature.
    Jankovic Makek M; Pavlisa G; Jakopovic M; Redzepi G; Zmak L; Vukic Dugac A; Hecimovic A; Mazuranic I; Jaksch P; Klepetko W; Samarzija M
    Transpl Infect Dis; 2016 Feb; 18(1):112-9. PubMed ID: 26556693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study in South Korea.
    Jung HI; Kim SA; Kim HJ; Yim JJ; Kwak N
    Chest; 2022 Apr; 161(4):918-926. PubMed ID: 34756943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review.
    Yeung MW; Khoo E; Brode SK; Jamieson FB; Kamiya H; Kwong JC; Macdonald L; Marras TK; Morimoto K; Sander B
    Respirology; 2016 Aug; 21(6):1015-25. PubMed ID: 27009804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study.
    Kim SJ; Yoon SH; Choi SM; Lee J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2017 Jan; 17(1):5. PubMed ID: 28056937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
    Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
    Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.
    Blakney RA; Ricotta EE; Follmann D; Drew J; Carey KA; Glass LN; Robinson C; MacDonald S; McShane PJ; Olivier KN; Fennelly K; Prevots DR
    BMC Infect Dis; 2022 Jan; 22(1):75. PubMed ID: 35062891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region.
    Wani SR; Wattal C; Raveendran R
    Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.